Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Journal of Epidemiology

• Publication date

  2017-03-15

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1093/aje/kww136PMID 28399570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt

  2015cited by this paper
• No Survival Benefit for Patients with Treatment in Certified Breast Centers—A Population‐based Evaluation of German Cancer Registry Data

  2015cited by this paper
• Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study

  2015cited by this paper
• A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry

  2012cited by this paper
• Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value.

  2012cited by this paper
• Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

  2011cited by this paper
• Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

  2010cited by this paper
• Registries for robust evidence.

  2009cited by this paper
• Developments in Post‐marketing Comparative Effectiveness Research

  2007cited by this paper
• Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

  2006cited by this paper
• Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error.

  2006cited by this paper
• Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review.

  2005cited by this paper
• A review of uses of health care utilization databases for epidemiologic research on therapeutics.

  2005cited by this paper
• Identifiability and Exchangeability for Direct and Indirect Effects

  1992cited by this paper
• Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error.

  1990cited by this paper
• Predictors of Response to Anti-tnf-therapy among Patients with Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register

  year unknowncited by this paper

• Propensity score trimming mitigates bias due to covariate measurement error in inverse probability of treatment weighted analyses: A plasmode simulation

  2021cites this paper
• Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance.

  2021cites this paper
• Determining the Best Methods for Using Patient Registry Data in Clinical Research

  2019cites this paper
• Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement

  2017cites this paper
• Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

  2017cites this paper
• When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

  2017cites this paper